Fred P. Lampropoulos - Mar 5, 2025 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
President and CEO, Director
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Stock symbol
MMSI
Transactions as of
Mar 5, 2025
Transactions value $
-$3,564,069
Form type
4
Date filed
3/6/2025, 05:40 PM
Previous filing
Mar 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Sale -$1.18M -11.3K -1.01% $104.05 1.11M Mar 5, 2025 Direct F3
transaction MMSI Common Stock, No Par Value Sale -$2.08M -20K -1.81% $103.75 1.09M Mar 5, 2025 Direct F4
transaction MMSI Common Stock, No Par Value Sale -$42.5K -410 -3.82% $103.75 10.3K Mar 5, 2025 By spouse F2
transaction MMSI Common Stock, No Par Value Sale -$269K -2.59K -25.09% $103.75 7.73K Mar 5, 2025 By spouse F2
holding MMSI Common Stock, No Par Value 97.8K Mar 5, 2025 By 401(k) Plan F1
holding MMSI Common Stock, No Par Value 90 Mar 5, 2025 By spouse as custodian for child F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MMSI Non-qualified stock options (right to buy) 159K Mar 5, 2025 Common Stock 159K $55.73 Direct F5
holding MMSI Non-qualified stock options (right to buy) 2K Mar 5, 2025 Common Stock 2K $55.73 By spouse F2, F6
holding MMSI Non-qualified stock options (right to buy) 100K Mar 5, 2025 Common Stock 100K $37.71 Direct F7
holding MMSI Non-qualified stock options (right to buy) 58.1K Mar 5, 2025 Common Stock 58.1K $56.25 Direct F8
holding MMSI Non-qualified stock options (right to buy) 54.3K Mar 5, 2025 Common Stock 54.3K $70.58 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents plan holdings as of 02/28/2025.
F2 Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
F3 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.00 to $104.22, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.75 to $103.765, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5 Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
F6 Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.
F7 Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
F8 Becomes exercisable in equal annual installments of 25% commencing 03/19/2022.
F9 Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.